Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhalable nanocatchers for SARS-CoV-2 inhibition

2 Jul 2021

Abstract excerpt

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2), presents an urgent health crisis. More recently, an increasing number of mutated strains of SARS-CoV-2 have been identified globally. Such mutations, especially those on the spike glycoprotein to render its higher binding affinity to human angiotensin-converting enzyme II...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inhalation and Respiratory Drug Delivery
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34292870
DOI: 10.1073/pnas.2102957118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhalable nanocatchers for SARS-CoV-2 inhibitionPMID 34292870Read ↗

Novel ACE2 nanoparticles universally block SARS-CoV-2 variants in the human respiratory tractSemantic proximity Read ↗

ACE2-Coated Virus-Like Particles Effectively Block SARS-CoV-2 InfectionSemantic proximity Read ↗

Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 EntrySemantic proximity Read ↗

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drugSemantic proximity Read ↗

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activitiesSemantic proximity Read ↗

Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2Semantic proximity Read ↗

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivoSemantic proximity Read ↗

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo.Semantic proximity Read ↗

Peptide Antidotes to SARS-CoV-2 (COVID-19)Semantic proximity Read ↗

High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting EnzymeSemantic proximity Read ↗

Rationally Designed, ACE2 Mimetic Binder to the SARS Cov-2 Associated Spike Protein for COVID-19 Therapeutics and BeyondSemantic proximity Read ↗

Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.